SureStep Foley Tray System - Product Usage: Intended for use in the drainage and/or collection an...
FDA Device Recall #Z-1970-2020 — Class II — April 15, 2020
Recall Summary
| Recall Number | Z-1970-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 15, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | C.R. Bard Inc |
| Location | Covington, GA |
| Product Type | Devices |
| Quantity | 8392 units |
Product Description
SureStep Foley Tray System - Product Usage: Intended for use in the drainage and/or collection and/or measurement of urine. Generally, drainage is accomplished by inserting the catheter through the urethra and into the bladder. However, drainage is sometimes accomplished by suprapubic or other placement of the catheter, such as a nephrostomy tract.
Reason for Recall
There is potential for a white paper-type residue attached to the catheter.
Distribution Pattern
US Nationwide distribution including in the states of AZ, CA, FL, GA, IA, IL, IN, KS, KY, MA, MD, MI, MO, NC, NE, NJ, NY, RI, SD, TN, TX, UT, VA, WV.
Lot / Code Information
Catalog Number: A304716A UDI: 00801741104299 Lot Numbers: NGDX4745 (Exp. 03/20/2021); NGDY0567 (Exp. 03/20/2021); NGDW1548 (Exp. 11/30/2021); NGDW0234 (Exp. 11/30/2021); NGDX4088 (Exp. 11/30/2021); NGDX4704 (Exp. 11/30/2021); NGDY0568 (Exp. 11/30/2021)
Other Recalls from C.R. Bard Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0906-2026 | Class II | BD InLay Optima Ureteral Stent Kit Size: 4.7 Fr... | Nov 6, 2025 |
| Z-0908-2026 | Class II | BD InLay Optima Ureteral Stent Kit Size: 8 Fr. ... | Nov 6, 2025 |
| Z-0907-2026 | Class II | BD InLay Optima Ureteral Stent Kit Size: 6 Fr. ... | Nov 6, 2025 |
| Z-0905-2026 | Class II | Bard InLay Optima Size: 6 Fr. x 14 cm, Ureteral... | Nov 6, 2025 |
| Z-2589-2025 | Class II | SureStep Foley Tray System Bardex I.C. Complete... | Jul 17, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.